Pyxis Oncology (PYXS) Other Working Capital Changes (2020 - 2025)

Pyxis Oncology (PYXS) has 6 years of Other Working Capital Changes data on file, last reported at $1.1 million in Q4 2025.

• On a quarterly basis, Other Working Capital Changes rose 187.1% year-over-year to $1.1 million in Q4 2025; TTM through Dec 2025 was $71000.0, a 105.77% increase from a year earlier, with the FY2025 full-year figure at $71000.0, up 105.77% from the prior year.
• Other Working Capital Changes for Q4 2025 stood at $1.1 million, up from -$1.1 million in the prior quarter.
• Over the last five years, Other Working Capital Changes for PYXS reached as high as $3.0 million in Q4 2022 and fell as low as -$2.0 million in Q2 2024.
• Historically, Other Working Capital Changes has averaged $161750.0 across 5 years, with a median of $151500.0 in 2021.
• Across the five-year window, Other Working Capital Changes surged 2406.25% in 2022 and tumbled 675.51% in 2024, its largest moves.
• Year by year, Other Working Capital Changes stood at -$160000.0 in 2021, then jumped by 2406.25% to $3.7 million in 2022, then plunged by 107.78% to -$287000.0 in 2023, then sank by 356.45% to -$1.3 million in 2024, then surged by 187.1% to $1.1 million in 2025.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were $1.1 million in Q4 2025, -$1.1 million in Q3 2025, and $376000.0 in Q2 2025.